NSRX
Nasus Pharma Ltd.
NYSE MKT: NSRX · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$2.75
+1.85% today
Updated 2026-05-01
Market cap
$37.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$0 – $10
Volume
0.2M
Nasus Pharma Ltd. (NSRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-107.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-1.71M | — | — | — |
| 2023 | $0.00 | $-1.05M | — | — | — |
| 2024 | $0.00 | $-1.53M | — | — | — |
| 2025 | $0.00 | $-5.86M | — | — | — |